133 related articles for article (PubMed ID: 16143294)
1. Gene expression profiling in INS-1 cells overexpressing thioredoxin-interacting protein.
Minn AH; Pise-Masison CA; Radonovich M; Brady JN; Wang P; Kendziorski C; Shalev A
Biochem Biophys Res Commun; 2005 Oct; 336(3):770-8. PubMed ID: 16143294
[TBL] [Abstract][Full Text] [Related]
2. High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice.
Masson E; Koren S; Razik F; Goldberg H; Kwan EP; Sheu L; Gaisano HY; Fantus IG
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1251-61. PubMed ID: 19223654
[TBL] [Abstract][Full Text] [Related]
3. Histone acetylation of glucose-induced thioredoxin-interacting protein gene expression in pancreatic islets.
Bompada P; Atac D; Luan C; Andersson R; Omella JD; Laakso EO; Wright J; Groop L; De Marinis Y
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):82-91. PubMed ID: 27989964
[TBL] [Abstract][Full Text] [Related]
4. Geniposide accelerates proteasome degradation of Txnip to inhibit insulin secretion in pancreatic β-cells.
Liu CY; Hao YN; Yin F; Zhang YL; Liu JH
J Endocrinol Invest; 2017 May; 40(5):505-512. PubMed ID: 28000177
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis.
Chen J; Saxena G; Mungrue IN; Lusis AJ; Shalev A
Diabetes; 2008 Apr; 57(4):938-44. PubMed ID: 18171713
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis.
Minn AH; Hafele C; Shalev A
Endocrinology; 2005 May; 146(5):2397-405. PubMed ID: 15705778
[TBL] [Abstract][Full Text] [Related]
7. Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals.
Hui TY; Sheth SS; Diffley JM; Potter DW; Lusis AJ; Attie AD; Davis RA
J Biol Chem; 2004 Jun; 279(23):24387-93. PubMed ID: 15047687
[TBL] [Abstract][Full Text] [Related]
8. Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets.
Shaked M; Ketzinel-Gilad M; Ariav Y; Cerasi E; Kaiser N; Leibowitz G
Diabetologia; 2009 Apr; 52(4):636-44. PubMed ID: 19214472
[TBL] [Abstract][Full Text] [Related]
9. Exenatide inhibits beta-cell apoptosis by decreasing thioredoxin-interacting protein.
Chen J; Couto FM; Minn AH; Shalev A
Biochem Biophys Res Commun; 2006 Aug; 346(3):1067-74. PubMed ID: 16782054
[TBL] [Abstract][Full Text] [Related]
10. [Effect of diabetic induced thioredoxin interacting protein (TXNIP) on islet cell senescence].
Huo HY; Wang J; Zhang XM; Zhang WT; Yue JP; Jiao XY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Mar; 36(2):119-123. PubMed ID: 32744003
[No Abstract] [Full Text] [Related]
11. W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.
Li T; Lin GY; Zhong L; Zhou Y; Wang J; Zhu Y; Feng Y; Cai XQ; Liu Q; Nosjean O; Boutin JA; Renard P; Yang DH; Wang MW
Acta Pharmacol Sin; 2017 Jul; 38(7):1024-1037. PubMed ID: 28502980
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin-interacting protein regulates insulin transcription through microRNA-204.
Xu G; Chen J; Jing G; Shalev A
Nat Med; 2013 Sep; 19(9):1141-6. PubMed ID: 23975026
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor Ets1 regulates expression of thioredoxin-interacting protein and inhibits insulin secretion in pancreatic β-cells.
Luo Y; He F; Hu L; Hai L; Huang M; Xu Z; Zhang J; Zhou Z; Liu F; Dai YS
PLoS One; 2014; 9(6):e99049. PubMed ID: 24897113
[TBL] [Abstract][Full Text] [Related]
14. Metabolism-independent sugar effects on gene transcription: the role of 3-O-methylglucose.
Minn AH; Couto FM; Shalev A
Biochemistry; 2006 Sep; 45(37):11047-51. PubMed ID: 16964965
[TBL] [Abstract][Full Text] [Related]
15. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
16. High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1.
Qi W; Chen X; Gilbert RE; Zhang Y; Waltham M; Schache M; Kelly DJ; Pollock CA
Am J Pathol; 2007 Sep; 171(3):744-54. PubMed ID: 17675577
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin Interacting Protein Inhibitors in Diabetes Mellitus: A Critical Review.
Kar A; Paramasivam B; Jayakumar D; Swaroop AK; Jubie S
Curr Drug Res Rev; 2023; 15(3):228-240. PubMed ID: 36786139
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin binding protein-2/thioredoxin-interacting protein is a critical regulator of insulin secretion and peroxisome proliferator-activated receptor function.
Oka S; Yoshihara E; Bizen-Abe A; Liu W; Watanabe M; Yodoi J; Masutani H
Endocrinology; 2009 Mar; 150(3):1225-34. PubMed ID: 18974273
[TBL] [Abstract][Full Text] [Related]
19. [Over-expression of thioredoxin-interacting protein promotes apoptosis of MIN6 cells via activating p38MAPK pathway].
Deng W; Li Y; Jia Y; Tang L; He Q; Liu D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1323-1327. PubMed ID: 29169415
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence.
Lim JY; Yoon SO; Hong SW; Kim JW; Choi SH; Cho JY
World J Gastroenterol; 2012 Oct; 18(39):5581-8. PubMed ID: 23112551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
